Research Analysts Offer Predictions for IPSC FY2024 Earnings
Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) – Investment analysts at Leerink Partnrs boosted their FY2024 earnings per share estimates for shares of Century Therapeutics in a note issued to investors on Thursday, February 13th. Leerink Partnrs analyst D. Graybosch now forecasts that the company will earn ($0.09) per share for the year, up from […]
Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) – Investment analysts at Leerink Partnrs boosted their FY2024 earnings per share estimates for shares of Century Therapeutics in a note issued to investors on Thursday, February 13th. Leerink Partnrs analyst D. Graybosch now forecasts that the company will earn ($0.09) per share for the year, up from […]
